Dilution of Share Value Through Stock Options
First written in FY2016. 20 of 25 entries say "Materialised", first in FY2017-Q2. Latest entry: FY2026.
Vega corporation moved to the "Worse" side of this theme in 2016, 4 years before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「1 April 2025–31 March 2026 (Note) Common shares 57,000」
From April 2025 through March 2026, 57,000 shares were issued through the exercise of stock acquisition rights, bringing part of the potential dilution from stock options into effect through the actual issuance of shares. - FY2026-H1MaterialisedAnnual report
「1 April 2025–30 September 2025 (Note) Common shares 43,200」
From April through September 2025, 43,200 shares were issued through the exercise of stock acquisition rights, bringing part of the potential dilution from stock options into effect through the actual issuance of shares. - FY2025MaterialisedAnnual report
「1 April 2024–31 March 2025 (Note) 2 Common shares 23,600」
In the fiscal year ended March 2025, 23,600 shares were issued through the exercise of stock acquisition rights, bringing part of the potential dilution from stock options into effect through the actual issuance of shares. The issuance of a further 12,800 shares from April through May 2025 is also disclosed. - FY2024MaterialisedAnnual report
「1 April 2023–31 March 2024 (Note) 1 Common shares 24,800」
During the fiscal year, 24,800 shares were issued through the exercise of stock acquisition rights, bringing part of the potential dilution from stock options into effect through the actual issuance of shares. - FY2024-Q2MaterialisedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights 326」
During the six-month period, the company recorded ¥326 thousand in proceeds from the issuance of shares through the exercise of stock acquisition rights, while total shares issued increased from 10,635,400 at the end of the previous quarter to 10,644,800. Part of the potential dilution has taken effect through the actual issuance of shares. - FY2023-Q1MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 1,200 10,635,400 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the first quarter accounting period resulted in the issuance of 1,200 shares, bringing part of the potential dilution into effect through the actual issuance of shares. - FY2022MaterialisedAnnual report
「1 April 2021–31 March 2022 (Note) 1 Common shares 600」
During the fiscal year, 600 shares were issued through the exercise of stock acquisition rights, bringing part of the potential dilution into effect through the actual issuance of shares. - FY2022-Q3MaterialisedAnnual report
「The number of shares issued as of the filing date does not include shares issued through the exercise of stock acquisition rights from 1 February 2022 through the filing date of this quarterly report.」
The number of shares issued was 10,634,200 as of the filing date, compared with 10,633,600 shares issued at the end of the third quarter accounting period, indicating that 600 shares had been issued through the exercise of stock acquisition rights. - FY2021MaterialisedAnnual report
「1 April 2020–31 March 2021 Common shares 93,800 Increase due to the exercise of stock acquisition rights as stock options.」
During the fiscal year, 93,800 shares were issued through the exercise of stock acquisition rights, bringing part of the potential dilution from stock options into effect through the actual issuance of shares. - FY2021-Q3MaterialisedAnnual report
「In addition, the exercise of stock acquisition rights as stock options resulted in the issuance of 61,400 shares, increasing both stated capital and capital surplus by ¥16.619 million.」
During the nine-month period, the exercise of stock acquisition rights resulted in the issuance of 61,400 shares, bringing part of the potential dilution into effect through the actual issuance of shares. - FY2021-Q2MaterialisedAnnual report
「In addition, the exercise of stock acquisition rights as stock options resulted in the issuance of 30,400 shares, increasing both stated capital and capital surplus by ¥8.350 million.」
The exercise of stock acquisition rights resulted in the issuance of 30,400 shares, bringing part of the potential dilution from stock options into effect through the actual issuance of shares. - FY2021-Q1MaterialisedAnnual report
「1 April 2020–30 June 2020 600 10,375,400 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the quarter resulted in the issuance of 600 shares, bringing part of the potential dilution into effect through the actual issuance of shares. - FY2020MaterialisedAnnual report
「1 April 2019–31 March 2020 (Note) Common shares 7,000」
During the fiscal year, 7,000 shares were issued through the exercise of stock acquisition rights, bringing part of the potential dilution into effect through the actual issuance of shares. - FY2020-Q1MaterialisedAnnual report
「1 April 2019–30 June 2019 (Note) 7,000 10,374,800 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the quarter resulted in the issuance of 7,000 shares, bringing part of the potential dilution into effect through the actual issuance of shares. - FY2019MaterialisedAnnual report
「1 April 2018–31 March 2019 (Note) 6 Common shares 20,800」
From April 2018 through March 2019, 20,800 shares were issued through the exercise of stock acquisition rights, bringing part of the potential dilution into effect through the actual issuance of shares. The company also disclosed that, as of the end of May 2019, potential shares totaled 328,400, equivalent to 3.2% of total shares issued. - FY2019-Q2MaterialisedAnnual report
「1 July 2018–30 September 2018 (Note) 1,200 10,367,800 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the second quarter accounting period increased the number of shares by 1,200, bringing the total number of shares issued to 10,367,800. - FY2019-Q1MaterialisedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the first quarter increased the number of shares by 19,600, bringing part of the potential dilution into effect through the actual issuance of shares. - FY2018SoftenedAnnual report
「As of the end of May 2018, the number of potential shares represented by these stock options was 346,000, equivalent to 3.3% of the total 10,366,000 shares issued.」
The number of potential shares and their ratio to total shares issued declined from 370,200 shares and 3.6% in the previous disclosure to 346,000 shares and 3.3%. - FY2018-Q2MaterialisedAnnual report
「1 July 2017–30 September 2017 (Note) 1,200 10,345,000」
The exercise of stock acquisition rights as stock options resulted in the issuance of 1,200 shares, bringing the total number of shares issued to 10,345,000. Part of the potential dilution has taken effect through the actual issuance of shares. - FY2018-Q1MaterialisedAnnual report
「The number of shares issued as of the filing date does not include shares issued through the exercise of stock acquisition rights from 1 August 2017 through the filing date of this quarterly report.」
The number of shares issued was 10,344,800 as of the filing date, compared with 10,343,800 shares issued at the end of the first quarter, indicating that 1,000 shares had actually been issued through the exercise of stock acquisition rights. - FY2017WorsenedAnnual report
「As of the end of May 2017, the number of potential shares represented by these stock options was 370,200, equivalent to 3.6% of the total 10,343,800 shares issued.」
The company disclosed 370,200 potential shares, equivalent to 3.6% of total shares issued, quantifying the potential dilution exposure. - FY2017-Q3WorsenedAnnual report
「Number of shares underlying stock acquisition rights (shares) 30,000」
Stock acquisition rights were issued during the third quarter accounting period, adding potential dilution exposure relating to 30,000 underlying shares. - FY2017-Q2MaterialisedAnnual report
「In addition, upon receiving ¥9.222 million in payment upon the exercise of stock acquisition rights as stock options (¥1,060 exercise price and ¥530 capitalized amount per share), we issued 8,700 new shares.」
The exercise of stock acquisition rights resulted in the actual issuance of 8,700 shares, bringing part of the potential dilution from stock options into effect. - FY2017-Q1WorsenedAnnual report
「The stock acquisition rights issued during the first quarter accounting period are as follows. Number of shares underlying the stock acquisition rights (shares) 30,500」
During the quarter, the Company issued stock acquisition rights underlying 30,500 shares, adding potential dilution exposure. - FY2016First statedAnnual report
「As of the end of May 2016, the number of potential shares underlying these stock options was 175,500, equivalent to 3.7% of the 4,742,900 issued shares.」
The Company discloses the possibility that the exercise of stock acquisition rights granted as incentives to directors, employees and others could dilute the value and voting percentages of existing shareholders.